Auna SA-Class A (NYSE:AUNA), a prominent Latin American healthcare platform, reported fourth-quarter and full-year 2025 financial results that presented a mixed picture, with a strong bottom-line beat contrasted against margin pressures and regional challenges. The market's initial reaction, a significant after-hours surge, suggests investors are focusing on the company's improved profitability and forward guidance.
Earnings and Revenue Versus Estimates
The company's performance for the fourth quarter notably exceeded analyst expectations on profitability, while revenue came in roughly in line with forecasts.
- Earnings Per Share (EPS): Auna reported an Adjusted Net Income per share of S/1.78 (approximately $1.82) for Q4 2025. This result substantially surpassed the analyst consensus estimate of $0.74.
- Revenue: Quarterly revenue reached S/1,133 million (approximately $1.155 billion), slightly above the analyst estimate of $1.131 billion.
For the full fiscal year 2025, the company's revenue of S/4,385 million was essentially flat on a reported basis, aligning with its earlier indications of a stabilization period. The standout figure for the year was the sharp increase in Adjusted Net Income to S/336 million, up from S/146 million in 2024.
Market Reaction and Price Action
The immediate market response to the earnings release was decisively positive. Shares of Auna surged approximately 15% in after-hours trading following the announcement. This sharp move indicates that investors are rewarding the significant earnings beat and the company's optimistic outlook for 2026. The positive reaction may also reflect relief that management addressed a period of significant selling pressure, attributing it to a specific shareholder situation they believe has now abated, potentially removing an overhang on the stock.
Key Takeaways from the Earnings Report
The press release outlined a year of stabilization and strategic repositioning, with distinct narratives across Auna's three core markets.
Regional Performance Divergence: The consolidated results masked sharply different performances by country. Peru was highlighted as a consistent performer, delivering solid growth in revenue and Adjusted EBITDA. Colombia met expectations while deliberately shifting its business model toward more stable risk-sharing agreements. The primary headwind came from Mexico, where operational challenges led to declines in both revenue and profitability. Management, however, stressed that new leadership and commercial initiatives have led to a clear stabilization and recovery in Mexico beginning in late Q4 and continuing into early 2026.
Margin Pressure and Profitability: While revenue was resilient, profitability metrics faced pressure. The consolidated Adjusted EBITDA margin declined to 20.9% for the full year and 19.5% for the quarter, primarily due to the difficulties in Mexico. The bright spot was a record-low medical loss ratio (MLR) of 48.5% in the oncology business, demonstrating improved pricing discipline and care management efficiency.
Strengthened Financial Foundation: The company emphasized successful operational and financial housekeeping. It completed an $825 million debt refinancing, which extended maturities and reduced interest expenses. Notably, free cash flow increased by 35% year-over-year, and the net leverage ratio was held stable at 3.6x despite operational stresses. Management reiterated a commitment to reducing leverage below 3x over the medium term.
Forward Outlook Versus Analyst Expectations
For the first time, Auna provided formal financial guidance for 2026, projecting both revenue and Adjusted EBITDA growth of approximately 12% on a constant-currency basis, within a range of 10% to 14%. This outlook appears bullish compared to current analyst projections. While direct comparisons are complex due to currency assumptions, the company's revenue growth midpoint of 12% suggests confidence in a return to organic growth, particularly in Mexico. The guidance implies a expectation of broadly stable margins year-over-year, supported by cost discipline and the recovery in its Mexican operations.
For a detailed look at Auna's historical earnings performance, you can review the data here. Furthermore, future analyst projections and estimates for revenue and EPS are available here.
Disclaimer: This article is for informational purposes only and does not constitute investment advice, financial analysis, or a recommendation to buy, sell, or hold any security. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions.
